[{"Assets_0_Q3_USD":"11576000000.0","CIK":"1585364","CommonStockDividendsPerShareDeclared_1_Q3_USD":"0.23","CommonStockSharesConverted_0_Q3_shares":"136500000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-1.13","EarningsPerShareBasic_3_Q3_USD":"0.09","EarningsPerShareDiluted_1_Q3_USD":"-1.13","EarningsPerShareDiluted_3_Q3_USD":"0.09","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"525800000.0","NetIncomeLossConverted_1_Q3_USD":"-154600000.0","NetIncomeLossConverted_3_Q3_USD":"12400000.0","OfficialName":"Perrigo Company plc Ordinary Shares","RevenuesConverted_1_Q3_USD":"1213700000.0","RevenuesConverted_3_Q3_USD":"3773800000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":"5820400000.0","StockholdersEquity_0_Q3_USD":"5820300000.0","Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"136500000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"137500000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"136500000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"136300000.0","filed":"20201105","footnote":null,"form":"10-Q","fp":"Q3","fy":"2020.0","name":"PERRIGO CO PLC","period":"20200930","qtrs":"3","uom":"USD"}]